The MiR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer Via PI3K/AKT/Notch Signaling Pathways

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2020 May 6

PMID 32368099

Citations 18

Authors

Lingming Kong

Peng Liu

Mingjun Zheng

Zhongpeng Wang

Yang Gao

Keke Liang

Huaitao Wang

Xiaodong Tan

Affiliations

Soon will be listed here.

Abstract

Purpose: Aberrant expression of microRNAs contributes to the progression of pancreatic cancer by targeting downstream genes. A novel regulatory axis, miR-1224-5p/ELF3, was identified by bioinformatic analysis and experimental verification. Studies of the underlying molecular mechanisms behind this axis lead to a better understanding of the development of pancreatic cancer.

Materials And Methods: The differential expression of miR-1224-5p and ELF3 was verified based on Gene Expression Omnibus (GEO) datasets and clinical samples. The relationship between miR-1224-5p and ELF3 was demonstrated by luciferase assay and Western blot. The related signaling pathways of the miR-1224-5p/ELF3 axis in pancreatic cancer were investigated by gene set enrichment analysis (GSEA) and verified by Western blot. An analysis between ELF3 expression and immune infiltration was performed. Cellular and animal experiments were utilized to explore the effects of miR-1224-5p and ELF3 in pancreatic cancer.

Results: Suppressed expression of miR-1224-5p in pancreatic tumor tissues and cancer cells was identified first. Furthermore, miR-1224-5p is correlated with clinicopathological features, and decreased expression of miR-1224-5p indicates poor prognosis. miR-1224-5p serves as a tumor suppressor and inhibits malignant behaviors of pancreatic cancer based on in vivo and in vitro assays. The putative target gene was predicted by bioinformatic analysis and confirmed by dual-luciferase reporter assay. Overexpression of ELF3 can improve the malignant behaviors of pancreatic cancer and demonstrates poor prognosis and advanced clinical stage. The inhibitory role of miR-1224-5p in pancreatic cancer is manifested by its direct targeting of ELF3. A negative correlation between ELF3 expression and immune cell infiltration was identified, suggesting an immunosuppressive state resulting from ELF3 overexpression. The PI3K/AKT/Notch signaling pathways and epithelial-to-mesenchymal transition (EMT) are important underlying mechanisms.

Conclusion: The miR-1224-5p/ELF3 axis may serve as a new diagnostic, therapeutic, and prognostic biomarker in pancreatic cancer. The related PI3K/AKT/Notch/EMT signaling pathways greatly promote the elucidation of the progression of pancreatic cancer.

Citing Articles

E74-like ETS transcription factor 3 expression and regulation in human intervertebral disc.

Gonzalez-Rodriguez M, Ait Eldjoudi D, Cordero-Barreal A, Farrag M, Varela-Garcia M, Ruiz-Fernandez C JOR Spine. 2025; 8(1):e70016.

PMID: 39877798 PMC: 11774240. DOI: 10.1002/jsp2.70016.

MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.

Tolue Ghasaban F, Ghanei M, Mahmoudian R, Taghehchian N, Abbaszadegan M, Moghbeli M Heliyon. 2024; 10(9):e30599.

PMID: 38726188 PMC: 11079401. DOI: 10.1016/j.heliyon.2024.e30599.

The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers.

Jafari S, Motedayyen H, Javadi P, Jamali K, Hasan-Abad A, Atapour A Front Oncol. 2024; 14:1355064.

PMID: 38559560 PMC: 10978783. DOI: 10.3389/fonc.2024.1355064.

Discovery of Transcription Factors Involved in the Maintenance of Resident Vascular Endothelial Stem Cell Properties.

Konishi H, Rahmawati F, Okamoto N, Akuta K, Inukai K, Jia W Mol Cell Biol. 2024; 44(1):17-26.

PMID: 38247234 PMC: 10829836. DOI: 10.1080/10985549.2023.2297997.

Krüppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors.

Tsai Y, Cheng K, Jiang S, Hawse J, Chuang S, Chen S J Biomed Sci. 2023; 30(1):39.

PMID: 37308977 PMC: 10258947. DOI: 10.1186/s12929-023-00937-z.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K . Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer. 2011; 50(8):585-97. DOI: 10.1002/gcc.20880. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X . Tumor suppressive role of miR-1224-5p in keloid proliferation, apoptosis and invasion via the TGF-β1/Smad3 signaling pathway. Biochem Biophys Res Commun. 2017; 495(1):713-720. DOI: 10.1016/j.bbrc.2017.10.070. View

Li B, Severson E, Pignon J, Zhao H, Li T, Novak J . Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016; 17(1):174. PMC: 4993001. DOI: 10.1186/s13059-016-1028-7. View

Winter J, Jung S, Keller S, Gregory R, Diederichs S . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11(3):228-34. DOI: 10.1038/ncb0309-228. View

Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M . Genomic spectra of biliary tract cancer. Nat Genet. 2015; 47(9):1003-10. DOI: 10.1038/ng.3375. View

Li Y, Sarkar F . MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer. Int J Biol Sci. 2016; 12(3):326-37. PMC: 4753161. DOI: 10.7150/ijbs.15017. View

10.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

11.

Bauer A, Keller A, Costello E, Greenhalf W, Bier M, Borries A . Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One. 2012; 7(4):e34151. PMC: 3325244. DOI: 10.1371/journal.pone.0034151. View

12.

Roy S, Bantel H, Wandrer F, Schneider A, Gautheron J, Vucur M . miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib. J Hepatol. 2017; 67(5):966-978. DOI: 10.1016/j.jhep.2017.06.007. View

13.

Gao J, Long B, Wang Z . Role of Notch signaling pathway in pancreatic cancer. Am J Cancer Res. 2017; 7(2):173-186. PMC: 5336494. View

14.

Kar A, Gutierrez-Hartmann A . ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2 breast cancer patients and is critical for tumorigenesis in HER2 breast cancer cells. Oncotarget. 2017; 8(41):69622-69640. PMC: 5642504. DOI: 10.18632/oncotarget.18710. View

15.

Zhao J, Ou B, Han D, Wang P, Zong Y, Zhu C . Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Mol Cancer. 2017; 16(1):70. PMC: 5372323. DOI: 10.1186/s12943-017-0629-4. View

16.

Yeung T, Leung C, Wong K, Gutierrez-Hartmann A, Kwong J, Gershenson D . ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget. 2017; 8(10):16951-16963. PMC: 5370013. DOI: 10.18632/oncotarget.15208. View

17.

Liu P, Kong L, Jin H, Wu Y, Tan X, Song B . Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis. Cancer Cell Int. 2019; 19:262. PMC: 6788113. DOI: 10.1186/s12935-019-0980-1. View

18.

Liu P, Weng Y, Sui Z, Wu Y, Meng X, Wu M . Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium. Sci Rep. 2016; 6:37606. PMC: 5116583. DOI: 10.1038/srep37606. View

19.

Qian J, Li R, Wang Y, Shi Y, Luan W, Tao T . MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 2015; 403(1-2):33-41. DOI: 10.1007/s11010-015-2334-1. View

20.

Mootha V, Lindgren C, Eriksson K, Subramanian A, Sihag S, Lehar J . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34(3):267-73. DOI: 10.1038/ng1180. View